Clinical Trial Update: Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

View source ↗

Summary

Clinical trial evaluating whether SGLT2 inhibitor therapy affects elastographic and molecular markers of liver injury in patients with type 2 diabetes and non-a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: Josip Juraj Strossmayer University of Osijek | Conditions: Non-Alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2 | Status: COMPLETED